4/A//SEC Filing
ROSSO LOUIS T 4/A
Accession 0000850693-05-000017
CIK 0000850693other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:54 PM ET
Size
6.2 KB
Accession
0000850693-05-000017
Insider Transaction Report
Form 4/AAmended
ALLERGAN INC(AGN)
ROSSO LOUIS T
Director
Transactions
- Award
Phantom Stock Units
2004-11-30$73.50/sh+27.21$2,000→ 21,798.35 total→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
- [F3]Previous amount erroneously reported. Holdings subsequently reported on 1-5-05 should be adjusted accordingly.
- [F4]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
- [F5]Previous stock price erroneously reported.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeother
Related Parties
1- filerCIK 0001016368
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 6:54 PM ET
- Size
- 6.2 KB